ENTBF - Entheon Biomedical Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-11-30
2021-11-30
2020-11-30
2020-03-31
Total Revenue
189.677
189.677
21.67
0
0
Cost of Revenue
-
-
12.54
0
-
Gross Profit
-
-
9.13
0
-
Operating Expenses
Research Development
1,199
1,199
1,495
442.56
-
Selling General and Administrative
2,589
2,589
7,133
3,931
144.514
Total Operating Expenses
3,790
3,790
9,115
4,377
144.514
Operating Income or Loss
-3,600
-3,600
-9,106
-4,377
-144.514
Interest Expense
0
-
-
-
0
Total Other Income/Expenses Net
1,538
1,538
209.284
-12.275
-22.271
Income Before Tax
-2,061
-2,061
-8,887
-4,381
-146.783
Income Tax Expense
0
-
-
-
0
Income from Continuing Operations
-2,061
-2,061
-8,887
-4,381
-146.783
Net Income
-8,521
-8,521
-8,887
-4,381
-146.783
Net Income available to common shareholders
-8,521
-8,521
-8,887
-4,381
-146.783
Basic EPS
-
-0.14
-0.16
-0.16
-0.02
Diluted EPS
-
-0.14
-0.16
-0.16
-0.02
Basic Average Shares
-
59,089
54,285
27,440
6,035
Diluted Average Shares
-
59,089
54,285
27,440
6,035
EBITDA
-
-3,598
-8,619
-4,374
-146.783